Skip to content

Protecting Patients from Deceptive Drug Ads Act

In committee: it can still change before the session ends.

US S 652 · Senate Bill · 119th Congress

Draft a letter
Stage
In committee
Started in
Senate
Sponsors
2
Latest action
Feb 20, 2025

What it does

This bill establishes civil penalties for false or misleading communications about prescription drugs by certain entities on social media. It also requires additional disclosures and reporting relating to drug advertisements on social media or via telehealth.

Official summary · Introduced in Senate · Feb 20, 2025

Titles and provisions can change as the bill moves.

Read the full textRead it on the official site

Where it stands

  1. Introduced (Done)

    Feb 20, 2025

  2. Committee (Current step)

    In committee · Feb 20, 2025

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Where it goes next

While a bill can still move, the questions are about people and money.

Work with this bill

Protecting Patients from Deceptive Drug Ads Act | 52